Zolid Plus 15/850mg Tablet – Once-Daily High-Impact Combo for Advanced Insulin Resistance
Zolid Plus 15/850mg Tablet – Once-Daily High-Impact Combo for Advanced Insulin Resistance
Zolid Plus 15/850mg Tablet – Once-Daily High-Impact Combo for Advanced Insulin Resistance
Description
Zolid Plus 15/850mg Tablet – Pioglitazone 15mg + Metformin 850mg Most-Prescribed Strength for Rapid HbA1c Drop
Zolid Plus 15/850mg is the world’s most commonly prescribed pioglitazone–metformin fixed-dose combination, delivering the optimal insulin-sensitising dose of Pioglitazone 15mg alongside a robust 850mg metformin core. This single evening tablet tackles severe hepatic insulin resistance and peripheral glucose uptake issues, routinely lowering HbA1c by 1.6–2.4% in patients with baseline levels above 9%. It is the preferred choice for overweight individuals with metabolic syndrome, non-alcoholic steatohepatitis (NASH), or long-standing type-2 diabetes who need aggressive yet hypo-safe correction.


